PubRank

F Bonilla

Author PubWeight™ 52.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000 6.38
2 Expression of Snail protein in tumor-stroma interface. Oncogene 2006 2.68
3 Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 2010 1.58
4 Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 1999 1.55
5 Prenatal diagnosis of sacrococcygeal teratomas by two- and three-dimensional ultrasound. Ultrasound Obstet Gynecol 2002 1.51
6 Epidemiological and clinical characteristics of occult bacteremia in an adult emergency department in Spain: influence of blood culture results on changes in initial diagnosis and empiric antibiotic treatment. Eur J Clin Microbiol Infect Dis 2004 1.50
7 Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 2001 1.34
8 Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 2012 1.32
9 Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002 1.26
10 Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 2003 1.25
11 Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 1999 1.22
12 DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene 2008 1.18
13 Snail1 controls TGF-β responsiveness and differentiation of mesenchymal stem cells. Oncogene 2012 1.15
14 SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene 2009 1.05
15 Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod 1999 1.04
16 Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol 2000 1.04
17 Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer 1999 1.03
18 Assessment of endometrial volume by three-dimensional ultrasound prior to embryo transfer: clues to endometrial receptivity. Hum Reprod 1999 1.02
19 Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. J Mol Med (Berl) 2011 1.02
20 Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br J Cancer 1999 1.01
21 SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene 2010 0.99
22 Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Oncogene 2001 0.98
23 Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Cancer Res 1996 0.97
24 Rapid-infusion rituximab in lymphoma treatment. Ann Oncol 2005 0.96
25 TP53 gene mutations in plasma DNA of cancer patients. Genes Chromosomes Cancer 1999 0.94
26 Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol 2012 0.93
27 Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer. Cancer Genet Cytogenet 1998 0.90
28 Wild type p73 overexpression and high-grade malignancy in breast cancer. Breast Cancer Res Treat 2001 0.87
29 Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J Clin Oncol 1998 0.84
30 Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res Treat 1999 0.84
31 Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer. Gut 2003 0.83
32 Mutational status of K-ras and TP53 genes in primary sarcomas of the heart. Br J Cancer 2000 0.82
33 EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages. Oncol Lett 2011 0.82
34 Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations. Genes Chromosomes Cancer 2001 0.80
35 Regulation of natural killer cytotoxicity by 1,25-dihydroxyvitamin D3. Cell Immunol 1989 0.79
36 Early diagnosis of conjoined twins using two-dimensional color Doppler and three-dimensional ultrasound. J Natl Med Assoc 1998 0.78
37 Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000. Cancer Res 2001 0.78
38 DNA damage after chemotherapy correlates with tumor response and survival in small cell lung cancer patients. Mutat Res 2000 0.78
39 Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status. Genes Chromosomes Cancer 2001 0.78
40 Cerebral infarction after cisplatin-based chemotherapy. Postgrad Med J 1994 0.77
41 Clinicopathological characteristics of breast carcinomas with allelic loss in the p73 region. Breast Cancer Res Treat 2000 0.77
42 Primary osteosarcoma of the meninges. Ann Oncol 1994 0.77
43 Low incidence of germline BRCA2 gene mutations among Spanish breast cancer patients. Oncology 1999 0.77
44 Thanatophoric dysplasia: ultrasound diagnosis. Ultrasound Q 2001 0.76
45 Participation of inositol trisphosphate and ryanodine receptors in Bufo arenarum oocyte activation. Zygote 2010 0.76
46 The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas. J Pathol 2006 0.76
47 [Bleeding duodenal varices]. Rev Esp Enferm Dig 1995 0.75
48 Role of phospholipase A2 pathway in regulating activation of Bufo arenarum oocytes. Zygote 2012 0.75
49 [Use of Helicobacter pylori (Hp) antigen test in stool samples to detect Hp infection]. Gastroenterol Hepatol 1999 0.75
50 [Symptomatic hemobilia following hepatic biopsy. Value of ultrasonography in the diagnosis and control of this complication]. Rev Esp Enferm Dig 1995 0.75
51 [Infection in the cancer patient. The management of neutropenic fever]. An Med Interna 1993 0.75
52 [Study of the renal function with radioisotopes]. Rev Clin Inst Matern Lisb 1968 0.75
53 Crohn's disease and leukemia. Dig Dis Sci 1985 0.75
54 Behaviour of the vitelline envelope in Bufo arenarum oocytes matured in vitro in blockade to polyspermy. Zygote 2006 0.75
55 Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3- CD2+ natural killer cells. Eur J Immunol 1988 0.75
56 Absence of point mutations at codon 17 of the mdm2 gene (serine 17) in human primary tumors. Mutat Res 2000 0.75
57 [Second tumors in patients treated for Hodgkin's disease]. Rev Clin Esp 1988 0.75
58 [Extra bone marrow dissemination of a solitary plasmacytoma of the bone]. Med Clin (Barc) 1985 0.75
59 Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relatives. Int J Oncol 1998 0.75
60 [Percutaneous fine-needle transhepatic cholangiography: 20 years later]. Gastroenterol Hepatol 1995 0.75
61 Spontaneous and LH-induced maturation in Bufo arenarum oocytes: importance of gap junctions. Zygote 2007 0.75
62 [Microangiopathic hemolytic anemia and gastric cancer]. Rev Esp Enferm Dig 1993 0.75
63 [Focal neurologic manifestations in a patient with mediterranean boutonneuse fever]. Med Clin (Barc) 1992 0.75
64 Breast angiosarcoma after radiation therapy. Acta Oncol 1995 0.75
65 [Preliminary study of the accuracy of bidimensional echography in ultrasonic measurement of the pelvic organs]. Rev Ginecol Obstet (Sao Paulo) 1976 0.75
66 Hodgkin's disease: unsuspected minimal activity in patients that die from causes other than tumoral progression. Leuk Lymphoma 2001 0.75
67 [Endocrine analysis in female sterility]. Acta Obstet Ginecol Hisp Lusit 1970 0.75
68 Multiple primary tumors and familial cancers. A case report. Tumori 1993 0.75
69 Severe hyponatremia and hypopituitarism. Nephron 1995 0.75
70 Abnormal frequencies of alleles in polymorphic markers of the 17q21 region is associated with breast cancer. Cancer Lett 1999 0.75
71 Non-tropical pyomyositis caused by Salmonella enterica enterica in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1992 0.75
72 Involvement of GABAA receptor in Bufo arenarum oocyte maturation. Zygote 2008 0.75
73 Prognostic implications of loss of heterozygosity in the 17q21 region in breast cancer. Int J Oncol 1997 0.75
74 Involvement of G protein and purines in Rhinella arenarum oocyte maturation. Zygote 2012 0.75
75 Participation of MAPK, PKA and PP2A in the regulation of MPF activity in Bufo arenarum oocytes. Zygote 2010 0.75
76 Three-dimensional inversion mode rendering in molar pregnancy. Ultrasound Obstet Gynecol 2008 0.75
77 BRCA1 mutations in patients with familial risk of breast cancer. Acta Oncol 1998 0.75
78 [Heart failure as an initial manifestation of Whipple's disease]. Med Clin (Barc) 1995 0.75
79 HDLive ultrasound images of ovarian dermoid cysts: diagnostic accuracy. Clin Exp Obstet Gynecol 2016 0.75
80 Effect of insulin on spontaneous and progesterone-induced GVBD on Bufo arenarum denuded oocytes. Zygote 2004 0.75
81 [Familial mediterranean fever or the need for an early diagnosis]. Rev Clin Esp 1992 0.75
82 Comparison of the long-term mortality in Hodgkin's disease patients with that of the general population. Ann Oncol 1999 0.75
83 Testicular germ cell tumor and Down syndrome. Tumori 2000 0.75
84 Correlation between the occurrence of lupus nephritis, anti-erythrocyte autoantibodies and V kappa haplotype in NZB x 129/J and NZB x SM/J recombinant inbred murine strains. Eur J Immunol 1991 0.75
85 Loss of heterozygosity at the ACTBP2 locus in lung cancer detected on Elchrom precast Spreadex gels. Ann N Y Acad Sci 2000 0.75
86 Activation of maturation promoting factor in Bufo arenarum oocytes: injection of mature cytoplasm and germinal vesicle contents. Zygote 2006 0.75
87 Hodgkin's disease: correlation between causes of death at autopsy and clinical diagnosis. Ann Oncol 2000 0.75
88 [The actual medical indications of therapeutic abortion (author's transl)]. Rev Esp Obstet Ginecol 1976 0.75
89 [Parotid hypertrophy in hepatic cirrhosis]. Rev Clin Esp 1978 0.75
90 Missense mutations in the transactivation region of the BRCA1 gene in breast cancer. Cancer Genet Cytogenet 1998 0.75